A more recent version of this regulatory record is available. This version is kept only as a historical record. Please see the Record history section for link to the most recent version.
List details
Basic info
Status | Consultation |
---|---|
Submitter | Sweden |
Submitter email | kemi@kemi.se |
Regulatory programme |
|
CLP Annex VI Index Number |
|
Remarks | The evaluation of this active substance for potential renewal of approval under REG. 1107/2009 is performed by the competent authorities of France, Hungary, the Netherlands, and Sweden. |
Classification
Harmonised classification at the time of the proposal |
|
---|---|
Proposed harmonised classification by the dossier submitter |
|
Hazard classes open for commenting | Physical hazards (solid substance); Health hazards except respiratory sensitisation and aspiration hazard; Environmental hazards |
Intention timeline
Date of intention | 2021-01-27 |
---|---|
Expected date of submission | 2021-06-15 |
Submitted for accordance check | 2021-06-15 |
Final submission date | 2021-09-15 |
Start of consultation | 2021-09-23 |
Deadline for commenting | 2021-11-22 |
Legal deadline for opinion adoption | 2023-03-17 |
Documents
CLH report |
|
---|---|
Annexes to the CLH Report |
|
Comments received |
|
Related substances
By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.
Related regulatory records
Record history
The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.
Dec. 6, 2021
- Comments received: https://echa.europa.eu/documents/10162/0138f86e-6a23-5bac-1942-6d7cce566570 → https://echa.europa.eu/documents/10162/5c76dfa9-3d43-ca18-89b4-d725a743737c
- Public consultations - received attachments: https://echa.europa.eu/documents/10162/46afc076-5464-dde9-6842-17834cdcb1ad
- Public consultations - received attachments: https://echa.europa.eu/documents/10162/e3a8acf1-c037-b5ea-2921-db8a6f2d53f8
- Public consultations - received attachments: https://echa.europa.eu/documents/10162/e9c1cb74-e174-2151-10bc-ed4a85f868e8
- Remarks: The evaluation of this active substance for potential renewal of approval under REG. 1107/2009 is performed by the competent authorities of France, Hungary, the Netherlands, and Sweden. → The evaluation of this active substance for potential renewal of approval under Reg. 1107/2009 is performed by the competent authorities of France, Hungary, Netherlands and Sweden.
- Status: Consultation → Opinion Development
April 26, 2022
- Annexes to the CLH Report: https://echa.europa.eu/documents/10162/801008c4-bf75-3812-e69f-5c41911f869a
- Annexes to the CLH Report: https://echa.europa.eu/documents/10162/e315af3c-0b97-8339-c0fc-716fd323f368
- Comments received: https://echa.europa.eu/documents/10162/8db0ac28-a6ee-a309-4c80-3f75651a4951
- Public consultations - received attachments: https://echa.europa.eu/documents/10162/3b54918f-f4f7-ac7b-c2a7-6a29bf54ba33
July 13, 2022
- Background document: https://echa.europa.eu/documents/10162/b723f715-98b4-dbc0-b4f3-ad5081142ddd
- Comments received: https://echa.europa.eu/documents/10162/5c76dfa9-3d43-ca18-89b4-d725a743737c → https://echa.europa.eu/documents/10162/15fbb1af-3e4d-b516-9cc4-0b48ef8dc409
- Comments received: https://echa.europa.eu/documents/10162/8db0ac28-a6ee-a309-4c80-3f75651a4951 → https://echa.europa.eu/documents/10162/8f8b6a87-8bd8-3cdd-0f70-587fbfb41beb
- Date of opinion: 2022-05-30
- RAC opinion: https://echa.europa.eu/documents/10162/882a2dc7-9e6f-b0ac-491a-ed3526b4018a
- RAC opinion: https://echa.europa.eu/documents/10162/9a6bdbf8-0d3c-c029-8256-2112189a6f85
- Status: Opinion Development → Opinion Adopted
Jan. 18, 2023
- RAC opinion: https://echa.europa.eu/documents/10162/882a2dc7-9e6f-b0ac-491a-ed3526b4018a → https://echa.europa.eu/documents/10162/5702e99d-d503-f154-226f-d8ab070ac47a
This version
Nov. 9, 2021
- Comments received: https://echa.europa.eu/documents/10162/0138f86e-6a23-5bac-1942-6d7cce566570
Oct. 8, 2021
- Annexes to the CLH Report: https://echa.europa.eu/documents/10162/093effff-11b6-f55a-7928-dcfd1a85626c
- Annexes to the CLH Report: https://echa.europa.eu/documents/10162/4019afd9-bca7-fa60-7cb9-0b9d7fe978c3
- Annexes to the CLH Report: https://echa.europa.eu/documents/10162/43207890-b9e0-9d96-a79b-7b65002b88ee
- Annexes to the CLH Report: https://echa.europa.eu/documents/10162/56bb92bc-e311-b9eb-331c-6043b72f12b2
- Annexes to the CLH Report: https://echa.europa.eu/documents/10162/6a8991e4-afec-3ece-72f1-9ad516b62d11
- Annexes to the CLH Report: https://echa.europa.eu/documents/10162/9ed03c38-3882-86d3-0366-509ceccef5dc
- Annexes to the CLH Report: https://echa.europa.eu/documents/10162/d569d67d-8b94-6d6b-d812-8a9c4aa4d457
- Annexes to the CLH Report: https://echa.europa.eu/documents/10162/d71ce936-9ae4-a8f2-6a18-0e6feefcb33a
- Annexes to the CLH Report: https://echa.europa.eu/documents/10162/f4681f04-944a-2573-083b-cda6a6547300
- CLH report: https://echa.europa.eu/documents/10162/dbb41ec0-d02a-3b03-4295-e8ebded4fe76
- Deadline for commenting: 2021-11-22
- Final submission date: 2021-09-15
- Hazard classes open for commenting: Physical hazards (solid substance); Health hazards except respiratory sensitisation and aspiration hazard; Environmental hazards
- Legal deadline for opinion adoption: 2023-03-17
- Status: Submitted → Consultation
- Start of consultation: 2021-09-23
July 1, 2021
- Proposed harmonised classification by the dossier submitter: Aquatic Chronic 2, H411
- Proposed harmonised classification by the dossier submitter: Eye Dam. 1, H318
- Status: Intention → Submitted
- Submitted for accordance check: 2021-06-15
- Submitter email: kemi@kemi.se
Add the related substance to your watchlist to monitor this regulatory record.